LHDX News and Press, Lucira Health Inc. From 04/13/21

Lucira Health ([[LHDX]] -18.7%) has extended its pre-market losses even further to drop by double-digit percentage points in the late trading hours after Bank of America downgraded the stock to underperform from neutral.The company’s preliminary Q1 2021 revenue was far below their esti...

After rising sharply on Monday, shares of medical technology company Lucira Health (NASDAQ: LHDX) are going in the opposite direction on Tuesday. The company's stock dropped by as much as 22.6% today and was down by 18.5% as of 1:51 p.m. EDT. Lucira Health did not report any news to...

Gainers: Mackinac Financial (MFNC) +56%.NovoCure (NVCR) +42%.vTv Therapeutics (VTVT) +42%.Digimarc (DMRC) +20%.PLBY Group (PLBY) +20%.Ballantyne Strong (BTN) +20%.Birks Group (BGI) +18%.Zai Lab (ZLAB) +16%.B. Riley Financial (RILY) +15%.Nam Tai Property (NTP) +14%.Losers: Brook...

Gainers: NovoCure (NVCR) +45%, vTv Therapeutics (VTVT) +28%, Rigel Pharmaceuticals (RIGL) +15%, Zai Lab (ZLAB) +14%, Vallon Pharmaceuticals (VLON) +10%.Losers: Avenue Therapeutics (ATXI) -17%, AdaptHealth (AHCO) -17%, Brook...

iRhythm continues to trade lower as analysts evaluate the impact of Novitas rate update on the company. Meanwhile, the recent FDA approvals have led Truist Securities to upgrade Bristol Myers.iRhythm downgraded at BTIG on uncertain outlookThe revision of Novitas reimbursement rates ...

Avenue Therapeutics (ATXI) -16% after FDA continues to review NDA for IV Tramadol.Lucira Health (LHDX) -12%.OrganiGram (OGI) -12% on FQ2 results.Zomedica (ZOM) -11%.Brooklyn ImmunoTherapeutics (BTX) -10%.Fortress Biotech (FBIO) -9%.Pintec Technology (PT) -8%.Digital Ally (...

Shares of medical technology company Lucira Health (NASDAQ: LHDX) rose sharply on Monday and ended the day up by 27% after climbing by as much as 41.3% earlier in the trading session. The reason for these gains was the fact that the U.S. Food and Drug Administration (FDA) issued an ...

Lucira Health ([[LHDX]] +7.3%)  announces that the U.S. FDA has issued an Emergency Use Authorization ((EUA)) for over the counter ((OTC)) sale of the LUCIRA CHECK IT test kit for COVID-19 that delivers PCR quality molecular accuracy in 30 minutes or less at home.The U.S. desig...

Reports Preliminary 2021 First Quarter Revenue and Business Update Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits, today announced the U.S. Food a...

Celcuity (CELC) +55% on licensing agreement up to $340M for breast cancer treatment gedatolisib.Affimed N.V. (AFMD) +29% on positive data from NK cells + AFM13 in solid tumors.Greenwich LifeSciences (GLSI) +29% on robust immune response Phase IIb data in breast cancer.Gulf Reso...